Diabetes treatment is constantly evolving, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the actions https://tiffanyhumb133749.wikicommunication.com/5870128/promising_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment